NCT02464891View on ClinicalTrials.gov

Complement Inhibition in aHUS Dialysis Patients

PHASE2TerminatedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

June 4, 2015

Primary Completion Date

July 13, 2017

Study Completion Date

July 13, 2017

Conditions

Atypical Hemolytic Uremic Syndrome

Interventions

DRUG

CCX168

Trial Locations (1)

Unknown

A.O. Papa Giovanni XXIII - U.O. Nefrologia e Dialisi/IRCCS IRFMN - Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò, Bergamo

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Amgen

INDUSTRY

lead

Mario Negri Institute for Pharmacological Research

OTHER